Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model.
暂无分享,去创建一个
J. Qi | E. Ruoslahti | J. Sutcliffe | J. Seo | J. Kusunose | K. Ferrara | Hua Zhang | H. Lindfors | A. Kheirolomoom | K. Watson | J. Kusunose
[1] Wei-Chiang Shen,et al. Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives , 2007, Pharmaceutical Research.
[2] J. Sutcliffe,et al. Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). , 2007, Nuclear medicine and biology.
[3] Michael J Sailor,et al. Biomimetic amplification of nanoparticle homing to tumors , 2007, Proceedings of the National Academy of Sciences.
[4] Janos Szebeni,et al. Methylation of the phosphate oxygen moiety of phospholipid‐methoxy(polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin production , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] Liang Li,et al. Three-layer matrix/sample preparation method for MALDI MS analysis of low nanomolar protein samples , 2006, Journal of the American Society for Mass Spectrometry.
[6] N. Goldstein,et al. Identification of cancer targets and therapeutics using phage display. , 2006, Current opinion in drug discovery & development.
[7] Silvia Muro,et al. Advanced drug delivery systems that target the vascular endothelium. , 2006, Molecular interventions.
[8] M. Wauben,et al. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. , 2006, Arthritis and rheumatism.
[9] Wadih Arap,et al. Vascular Targeting: Recent Advances and Therapeutic Perspectives , 2006, Trends in Cardiovascular Medicine.
[10] E. Ruoslahti,et al. Molecular Profiling of Heart Endothelial Cells , 2005, Circulation.
[11] Simon C Watkins,et al. Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[13] R. Marchant,et al. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system , 2004, Thrombosis and Haemostasis.
[14] Vladimir P Torchilin,et al. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[15] E. Ruoslahti,et al. Vascular zip codes in angiogenesis and metastasis. , 2004, Biochemical Society transactions.
[16] A. Bao,et al. Direct 99mTc Labeling of Pegylated Liposomal Doxorubicin (Doxil) for Pharmacokinetic and Non-Invasive Imaging Studies , 2004, Journal of Pharmacology and Experimental Therapeutics.
[17] Mouldy Sioud,et al. Selective targeting of cancer cells using synthetic peptides. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[18] R. Schiffelers,et al. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[19] F. Pastorino,et al. Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma. , 2003, Cancer letters.
[20] L. Cipelletti,et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. , 2002, Blood.
[21] M. Shive,et al. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[22] Erkki Ruoslahti,et al. Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature , 2001, Arthritis research.
[23] J. Logan. Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.
[24] J. Kamps,et al. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] N. Van Rooijen,et al. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.
[26] S. Kennel,et al. Lipid composition is important for highly efficient target binding and retention of immunoliposomes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Bao,et al. Complexes: In Vitro Stability, Imaging, and Biodistribution in Rats , 2003 .
[28] Sutcliffe-Goulden Jl,et al. The synthesis of novel 18F-labelled peptides for PET. , 2002 .
[29] W. Chan,et al. Fmoc Solid Phase Peptide Synthesis: A Practical Approach (Practical Approach Series) , 2019 .
[30] C. Tilcock,et al. 99mTc-labeling of lipid vesicles containing the lipophilic chelator PE-DTTA: effect of tin-to-chelate ratio, chelate content and surface polymer on labeling efficiency and biodistribution behavior. , 1994, Nuclear medicine and biology.